Correlation Between 90331HPL1 and Recursion Pharmaceuticals
Specify exactly 2 symbols:
By analyzing existing cross correlation between US BANK NATIONAL and Recursion Pharmaceuticals, you can compare the effects of market volatilities on 90331HPL1 and Recursion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 90331HPL1 with a short position of Recursion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of 90331HPL1 and Recursion Pharmaceuticals.
Diversification Opportunities for 90331HPL1 and Recursion Pharmaceuticals
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between 90331HPL1 and Recursion is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding US BANK NATIONAL and Recursion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Recursion Pharmaceuticals and 90331HPL1 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on US BANK NATIONAL are associated (or correlated) with Recursion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Recursion Pharmaceuticals has no effect on the direction of 90331HPL1 i.e., 90331HPL1 and Recursion Pharmaceuticals go up and down completely randomly.
Pair Corralation between 90331HPL1 and Recursion Pharmaceuticals
Assuming the 90 days trading horizon US BANK NATIONAL is expected to generate 15.3 times more return on investment than Recursion Pharmaceuticals. However, 90331HPL1 is 15.3 times more volatile than Recursion Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Recursion Pharmaceuticals is currently generating about 0.02 per unit of risk. If you would invest 9,516 in US BANK NATIONAL on September 21, 2024 and sell it today you would earn a total of 31.00 from holding US BANK NATIONAL or generate 0.33% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 63.1% |
Values | Daily Returns |
US BANK NATIONAL vs. Recursion Pharmaceuticals
Performance |
Timeline |
US BANK NATIONAL |
Recursion Pharmaceuticals |
90331HPL1 and Recursion Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with 90331HPL1 and Recursion Pharmaceuticals
The main advantage of trading using opposite 90331HPL1 and Recursion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 90331HPL1 position performs unexpectedly, Recursion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Recursion Pharmaceuticals will offset losses from the drop in Recursion Pharmaceuticals' long position.90331HPL1 vs. NuRAN Wireless | 90331HPL1 vs. Compania Cervecerias Unidas | 90331HPL1 vs. Anheuser Busch Inbev | 90331HPL1 vs. Anterix |
Recursion Pharmaceuticals vs. Absci Corp | Recursion Pharmaceuticals vs. Affimed NV | Recursion Pharmaceuticals vs. Sana Biotechnology | Recursion Pharmaceuticals vs. Relay Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |